Total Payments
$20,067
2024 Payments
$2,811
Companies
86
Transactions
915
Medicare Patients
2,665
Medicare Billing
$547,580
Payment Breakdown by Category
Food & Beverage$19,342 (96.4%)
Education$725.23 (3.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,342 | 898 | 96.4% |
| Education | $725.23 | 17 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,357 | 48 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,064 | 49 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,018 | 53 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $999.85 | 52 | $0 (2024) |
| Amgen Inc. | $844.46 | 41 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $812.26 | 39 | $0 (2024) |
| Celgene Corporation | $739.65 | 44 | $0 (2024) |
| Janssen Biotech, Inc. | $723.90 | 21 | $0 (2024) |
| Eisai Inc. | $716.28 | 31 | $0 (2024) |
| Incyte Corporation | $694.41 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,811 | 111 | E.R. Squibb & Sons, L.L.C. ($285.33) |
| 2023 | $5,672 | 225 | AstraZeneca Pharmaceuticals LP ($456.81) |
| 2022 | $4,285 | 213 | Novartis Pharmaceuticals Corporation ($405.52) |
| 2021 | $4,380 | 233 | Incyte Corporation ($260.29) |
| 2020 | $1,921 | 88 | Merck Sharp & Dohme Corporation ($210.56) |
| 2019 | $207.31 | 7 | Takeda Pharmaceuticals U.S.A., Inc. ($100.00) |
| 2018 | $136.39 | 8 | ARBOR PHARMACEUTICALS, INC. ($69.85) |
| 2017 | $653.80 | 30 | GENZYME CORPORATION ($134.89) |
All Payment Transactions
915 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: ONC | ||||||
| 12/18/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Oncology | ||||||
| 12/17/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.17 | General |
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $22.98 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.84 | General |
| 11/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Oncology | ||||||
| 11/15/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $18.48 | General |
| Category: Hematology/Oncology | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug), REBLOZYL | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $15.69 | General |
| Category: Hematology | ||||||
| 11/04/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug), Somatuline Depot | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Oncology | ||||||
| 11/01/2024 | BeiGene USA, Inc. | TEVIMBRA (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $16.48 | General |
| Category: Hematology | ||||||
| 10/31/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $58.49 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 457 | 3,440 | $130,185 | $49,008 |
| 2022 | 33 | 1,059 | 19,900 | $625,891 | $246,604 |
| 2021 | 23 | 706 | 10,447 | $438,234 | $189,578 |
| 2020 | 18 | 443 | 3,905 | $183,743 | $62,391 |
Total Patients
2,665
Total Services
37,692
Medicare Billing
$547,580
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 137 | $36,325 | $12,784 | 35.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 23 | 101 | $29,733 | $12,346 | 41.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 27 | 70 | $10,492 | $3,667 | 35.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 21 | $7,940 | $3,151 | 39.7% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 26 | 112 | $7,294 | $2,865 | 39.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 39 | $7,122 | $2,550 | 35.8% |
| 36591 | Collection of blood sample from implanted device | Office | 2023 | 20 | 94 | $5,654 | $2,174 | 38.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 22 | $6,110 | $1,676 | 27.4% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 12 | 44 | $2,659 | $1,350 | 50.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 108 | $3,304 | $1,312 | 39.7% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 11 | 50 | $3,023 | $1,299 | 43.0% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 11 | 203 | $3,320 | $1,184 | 35.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 20 | 22 | $4,128 | $1,120 | 27.1% |
| 96368 | Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | Office | 2023 | 11 | 34 | $1,435 | $617.52 | 43.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 32 | 57 | $509.95 | $390.60 | 76.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 22 | 36 | $501.93 | $273.96 | 54.6% |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | Office | 2023 | 16 | 1,256 | $227.48 | $87.74 | 38.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 18 | 950 | $220.70 | $87.10 | 39.5% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2023 | 11 | 38 | $84.98 | $36.33 | 42.8% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 21 | 46 | $102.69 | $36.18 | 35.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 11 | 4,500 | $194,119 | $77,020 | 39.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 46 | 300 | $97,038 | $38,602 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 116 | 273 | $77,730 | $29,817 | 38.4% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2022 | 21 | 4,170 | $68,826 | $26,971 | 39.2% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 51 | 339 | $23,634 | $9,472 | 40.1% |
About Dr. David Morrison, MD
Dr. David Morrison, MD is a Hematology & Oncology healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811904188.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Morrison, MD has received a total of $20,067 in payments from pharmaceutical and medical device companies, with $2,811 received in 2024. These payments were reported across 915 transactions from 86 companies. The most common payment nature is "Food and Beverage" ($19,342).
As a Medicare-enrolled provider, Morrison has provided services to 2,665 Medicare beneficiaries, totaling 37,692 services with total Medicare billing of $547,580. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology, Hematology & Oncology
- Location New Orleans, LA
- Active Since 08/01/2006
- Last Updated 01/30/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1811904188
Products in Payments
- KEYTRUDA (Biological) $973.05
- OPDIVO (Biological) $782.50
- IMBRUVICA (Drug) $749.36
- Lenvima (Drug) $716.28
- Stivarga (Drug) $421.43
- MONJUVI (Drug) $399.54
- REBLOZYL (Biological) $378.38
- ZEJULA (Drug) $363.13
- DARZALEX (Biological) $359.82
- ERLEADA (Drug) $330.73
- KISQALI (Drug) $326.94
- TAGRISSO (Drug) $324.38
- LYNPARZA (Drug) $323.03
- Trodelvy (Drug) $308.22
- XPOVIO (Drug) $303.02
- LUMAKRAS (Drug) $294.11
- JAKAFI (Drug) $285.11
- NINLARO (Drug) $284.84
- GILOTRIF (Drug) $251.81
- Kyprolis (Drug) $243.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in New Orleans
Pedro Barata, M.d, M.D
Hematology & Oncology — Payments: $610,618
Hematology & Oncology $610,618
Furhan Yunus, Md, MD
Hematology & Oncology — Payments: $156,701
Hematology & Oncology $156,701
Scott Sonnier, Md, MD
Hematology & Oncology — Payments: $20,534
Hematology & Oncology $20,534
Sukanthini Subbiah, M.d, M.D
Hematology & Oncology — Payments: $12,772
Hematology & Oncology $12,772
Robert Veith, M.d, M.D
Hematology & Oncology — Payments: $12,408
Hematology & Oncology $12,408
Dr. Salvador Caputto, Md, MD
Hematology & Oncology — Payments: $9,385
Hematology & Oncology $9,385